Thursday, 18 April 2024

Australia's most trusted
source of pharma news

Thursday, 18 April 2024
Listen to this story 

Calls for heart disease screening

 Posted 3 April 2024 AM

The Heart Foundation is calling for the Albanese Government to fund Australia's first targeted heart disease screening program in this year's Federal Budget, to serve as an "early alert" for high risk patients, with the potential to save tens of thousands of Australians from heart attacks, strokes and heart-related deaths.

The high-profile lobby group wants the government to bankroll the initiative, starting with an initial allocation of  $3.3 million in the upcoming financial year to design the program. Heart Foundation Healthcare Programs Manager Natalie Raffoul said despite coronary heart disease being the leading cause of death in Australia, the onus is currently placed on individuals to voluntarily present to their GP for a preventative check.

To see the whole article, please login

Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (20)

Clinical & Medical, R&D (15)

Regulatory, Pharmacovigilance & QA (7)

Devices (1)

Other (32)

Email this article to a friend

Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.


Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.


Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).


You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.


You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.